<p><h1>Drug-Eluting Balloons Market Provides a Comprehensive Analysis Including a Macro Overview of the Market as well as Micro Details such as Market Size and Competitive Landscape</h1></p><p><strong>Drug-Eluting Balloons Market Analysis and Latest Trends</strong></p>
<p><p>Drug-eluting balloons (DEB) are medical devices used in the treatment of various cardiovascular diseases, including coronary artery disease and peripheral arterial disease. These balloons are coated with a drug that is released into the affected blood vessel when the balloon is inflated, providing targeted drug delivery to the specific area.</p><p>The drug-eluting balloons market has witnessed significant growth in recent years due to the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in balloon technologies. According to market analysis, the global drug-eluting balloons market is expected to grow at a CAGR of 5.1% during the forecast period.</p><p>One of the latest trends in the drug-eluting balloons market is the development of bioresorbable coatings on the balloons. These coatings are designed to dissolve after delivering the drug, eliminating the need for long-term foreign material in the body. This trend is driven by the need for improved patient outcomes and reduced long-term risks associated with foreign materials.</p><p>Another trend in the market is the development of drug-eluting balloons for the treatment of various diseases other than cardiovascular. Manufacturers are exploring the potential of using DEBs in areas such as cancer treatment and urology.</p><p>Geographically, North America holds the largest share in the drug-eluting balloons market, attributed to the high prevalence of cardiovascular diseases and the presence of advanced healthcare infrastructure. However, the Asia Pacific region is expected to witness significant growth during the forecast period due to the increasing healthcare expenditure and improving healthcare infrastructure.</p><p>Overall, the drug-eluting balloons market is set to grow steadily in the coming years, driven by technological advancements, increasing disease prevalence, and a growing demand for minimally invasive treatment options.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695092">https://www.reliableresearchreports.com/enquiry/request-sample/1695092</a></strong></p>
<p>&nbsp;</p>
<p><strong>Drug-Eluting Balloons Major Market Players</strong></p>
<p><p>The drug-eluting balloons (DEBs) market is highly competitive, with several key players dominating the industry. Some of the prominent players in this market include Boston Scientific, Medtronic, Cook Medical, C.R. Bard, B. Braun, Eurocor GmbH, Blue Medical, Bayer, Aachen Resonance, and Acrostak.</p><p>Boston Scientific, a leading medical device manufacturer, has a strong presence in the global DEB market. The company's DEB product portfolio includes the Ranger Drug Coated Balloon and the Opulence Drug Coated Balloon. Boston Scientific has a history of innovation in the market and has been invested in extensive research and development efforts to improve patient outcomes. The company has experienced consistent market growth and currently holds a significant market share.</p><p>Medtronic, another major player in the DEB market, offers the IN.PACT Admiral Drug-Coated Balloon. The company is known for its strong focus on innovation and has been actively involved in clinical studies to demonstrate the safety and efficacy of its DEB products. Medtronic's DEB business has witnessed substantial growth, with increased adoption of its products across different regions.</p><p>Cook Medical, a global medical device company, has established its presence in the DEB market with the introduction of its line of DEB products, including the Advance Saliva 35 and Advance Saliva 50. Cook Medical has gained market share through its commitment to quality and customer satisfaction. The company's DEB products have a favorable reputation among healthcare professionals and have contributed to its revenue growth in the market.</p><p>C.R. Bard, now part of Becton, Dickinson and Company, offers the Lutonix Drug-Coated Balloon for the treatment of peripheral artery disease. The company has a long-standing history in the medical device industry and has expanded its product portfolio through collaborations and acquisitions. C.R. Bard has experienced steady growth in the DEB market, fueled by the increasing prevalence of peripheral artery disease and the adoption of its high-quality DEB products.</p><p>While specific sales revenue figures were not provided, it is worth noting that the DEB market has been witnessing significant growth globally. Factors such as the rising prevalence of cardiovascular diseases, the increasing aging population, and the demand for minimally invasive treatment options have contributed to the expansion of the DEB market. With ongoing advancements in technology and increasing investments in research and development, the market is expected to continue its growth trajectory in the coming years.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Drug-Eluting Balloons Manufacturers?</strong></p>
<p><p>The drug-eluting balloons market is witnessing significant growth due to the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. Data shows that the market is projected to grow at a CAGR of around 4-5% over the next five years. The growth is driven by factors such as technological advancements in drug-eluting balloon devices, increasing awareness about their benefits, and a growing geriatric population. Additionally, the future outlook of the market looks promising with the development of innovative drug-eluting balloon solutions and expanding applications in various medical fields. Overall, the market is expected to experience steady growth in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695092">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695092</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Drug-Eluting Balloons Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Coronary Drug Eluting Balloon</li><li>Peripheral Drug Eluting Balloon</li><li>Others</li></ul></p>
<p><p>The Drug-Eluting Balloons (DEB) market is categorized into three types: Coronary Drug-Eluting Balloons (CDEB), Peripheral Drug-Eluting Balloons (PDEB), and Others. CDEB is used in coronary artery disease treatment, where the balloon is coated with medication that gets released during balloon inflation, reducing the chance of restenosis. PDEB is utilized in peripheral artery disease treatment, where the balloon delivers medication directly to the affected area of blood vessels, preventing restenosis. The "Others" category includes DEB solutions for non-coronary and non-peripheral applications, catering to specific medical requirements outside these major areas.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1695092">https://www.reliableresearchreports.com/purchase/1695092</a></strong></p>
<p>&nbsp;</p>
<p><strong>The Drug-Eluting Balloons Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals and Ambulatory Surgery Centers</li><li>CATH Labs</li><li>Others</li></ul></p>
<p><p>The Drug-Eluting Balloons Market finds applications in various healthcare settings including hospitals and ambulatory surgery centers, CATH labs, and others. Hospitals and ambulatory surgery centers utilize drug-eluting balloons for performing interventional procedures, such as angioplasty, on patients with coronary artery disease. CATH labs, specialized facilities within hospitals, also employ these balloons for treating cardiac conditions. Furthermore, drug-eluting balloons are used in other healthcare settings, enabling physicians to deliver medication directly to affected areas during various procedures, resulting in improved patient outcomes.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Drug-Eluting Balloons Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The drug-eluting balloons market is projected to experience substantial growth in regions such as North America (NA), Asia-Pacific (APAC), Europe, the United States of America (USA), and China. This can be attributed to various factors, including the increasing prevalence of cardiovascular diseases and a rising geriatric population. Among these regions, North America is expected to dominate the market, driven by advancements in healthcare infrastructure and high healthcare expenditure. Currently, North America holds a significant market share, accounting for approximately XX% of the total valuation. APAC and Europe are also anticipated to exhibit significant growth and capture a substantial market share in the drug-eluting balloons market.</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1695092">https://www.reliableresearchreports.com/purchase/1695092</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695092">https://www.reliableresearchreports.com/enquiry/request-sample/1695092</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@stand.tough.park/two-wheeler-in-wheel-motor-market-furnishes-information-on-market-share-market-trends-and-market-20bbae041c59">Two-wheeler In-wheel Motor Market</a></p><p><a href="https://medium.com/@press.bell.sigh/vehicle-urea-tank-market-competitive-analysis-market-trends-and-forecast-to-2030-f15cd2db6b6f">Vehicle Urea Tank Market</a></p><p><a href="https://www.linkedin.com/pulse/memory-impairment-treatment-market-challenges-opportunities-zw8be/">Memory Impairment Treatment Market</a></p><p><a href="https://github.com/kuntayevaz/Market-Research-Report-List-1/blob/main/end-of-line-packaging-machines-market.md">End-of-Line Packaging Machines Market</a></p><p><a href="https://www.linkedin.com/pulse/venipuncture-procedure-market-size-share-amp-trends-analysis-ltepe/">Venipuncture Procedure Market</a></p></p>